In the century since Alois Alzheimer discovered Alzheimer’s disease (AD), scientists have made remarkable strides in understanding the illness [1], although it was not until the 1980s that two key molecular culprits in disease pathophysiology, amyloid beta (Aβ) and tau proteins, were identified [2, 3]. This evidence concerns the gene MAPT and Alzheimer disease.